Dystonic Storm

Chapter
Part of the Current Clinical Neurology book series (CCNEU)

Abstract

In rare cases, generalized dystonia can rapidly progress to cause severe, continuous forceful contractions. This phenomenon—referred to as “dystonic storm” or “status dystonicus”—is a severe, life-threatening crisis that requires urgent evaluation and treatment. Dystonic storm can occur in idiopathic dystonia, or in symptomatic dystonia due to trauma, encephalitis, static encephalopathy, acute neuroleptic exposure, or neurodegenerative disorders. The differential diagnosis of dystonic storm includes bacterial meningitis, neuroleptic malignant syndrome, serotonin syndrome, malignant hyperthermia, and intrathecal baclofen withdrawal. Treatments for dystonic storm are empiric, and can be divided into three categories: supportive care, temporizing measures, and dystonia-specific treatments. Supportive care includes admission to an intensive care unit, mechanical ventilation, treatment with intravenous fluids and antipyretics, and monitoring of creatine phosphokinase, renal function, and urine output. Potential triggers (such as infection or medications) should also be identified and treated. Temporizing measures include the use of sedative-hypnotics, general anesthetics, or non-depolarizing paralytic agents. Dystonia-specific therapies should begin with catecholamine-depleting agents, anticholinergics, and/or dopamine receptor blocking agents. Other medications that may be effective include baclofen and benzodiazepines. If oral dystonia therapies are ineffective, then interventions such as an intrathecal baclofen pump or deep brain stimulation of the globus pallidus interna should be considered.

Supplementary material

Movement_Disorders_Emergencies_C9.mov (110,800 KB)

References

  1. 1.
    Fahn S. Concept and classification of dystonia. Adv Neurol. 1988;50:1–8.PubMedGoogle Scholar
  2. 2.
    Friedman J, Standaert DG. Dystonia and its disorders. Neurol Clin. 2001;19:681–705.PubMedCrossRefGoogle Scholar
  3. 3.
    Jankovic J, Penn AS. Severe dystonia and myoglobinuria. Neurology. 1982;32:1195–7.PubMedCrossRefGoogle Scholar
  4. 4.
    Marsden CD, Marion MH, Quinn N. The treatment of severe dystonia in children and adults. J Neurol Neurosurg Psychiatry. 1984;47:1166–73.PubMedCrossRefGoogle Scholar
  5. 5.
    Manji H, Howard RS, Miller DH, et al. Status dystonicus: the syndrome and its management. Brain. 1998;121:243–52.PubMedCrossRefGoogle Scholar
  6. 6.
    Svetel M, Sternic N, Pejovic S, Kostic VS. Penicillamine-induced lethal status dystonicus in a patient with Wilson’s disease. Mov Disord. 2001;16:568–9.PubMedCrossRefGoogle Scholar
  7. 7.
    Opal P, Tintner R, Jankovic J, et al. Intrafamilial phenotypic variability of the DYT1 dystonia: from asymptomatic TOR1A gene carrier status to dystonic storm. Mov Disord. 2002;17:339–45.PubMedCrossRefGoogle Scholar
  8. 8.
    Dalvi A, Fahn S, Ford B. Intrathecal baclofen in the treatment of dystonic storm. Mov Disord. 1998;13:611–2.PubMedCrossRefGoogle Scholar
  9. 9.
    Vaamonde J, Narbona J, Weiser R, Garcia MA, Brannan T, Obeso JA. Dystonic storms: a practical management problem. Clin Neuropharmacol. 1994;17:344–7.PubMedCrossRefGoogle Scholar
  10. 10.
    Paret G, Tirosh R, Ben-Zeev B, Vardi A, Brandt N, Barzilay Z. Rhabdomyolysis due to hereditary torsion dystonia. Pediatr Neurol. 1995;13:83–4.PubMedCrossRefGoogle Scholar
  11. 11.
    Teive HA, Munhoz RP, Souza MM, et al. Status dystonicus: study of five cases. Arq Neuropsiquiatr. 2005;63:26–9.PubMedCrossRefGoogle Scholar
  12. 12.
    Narayan RK, Loubser PG, Jankovic J, Donovan WH, Bontke CF. Intrathecal baclofen for intractable axial dystonia. Neurology. 1991;41:1141–2.PubMedCrossRefGoogle Scholar
  13. 13.
    Samson-Fang L, Gooch J, Norlin C. Intrathecal baclofen withdrawal simulating neuroepileptic malignant syndrome in a child with cerebral palsy. Dev Med Child Neurol. 2000;42:561–5.PubMedCrossRefGoogle Scholar
  14. 14.
    Watemberg N, Leshner RL, Armstrong BA, Lerman-Sagie T. Acute pediatric rhabdomyolysis. J Child Neurol. 2000;15:222–7.PubMedCrossRefGoogle Scholar
  15. 15.
    Mariotti P, Fasano A, Contarino MF, et al. Management of status dystonicus: our experience and review of the literature. Mov Disord. 2007;22:963–8.PubMedCrossRefGoogle Scholar
  16. 16.
    Ravi SD, Borge GF, Roach FL. Neuroleptics, laryngeal-pharyngeal dystonia and acute renal failure. J Clin Psychiatry. 1982;43:300.PubMedGoogle Scholar
  17. 17.
    Cavanaugh JJ, Finlayson RE. Rhabdomyolysis due to acute dystonic reaction to antipsychotic drugs. J Clin Psychiatry. 1984;45:356–7.PubMedGoogle Scholar
  18. 18.
    Delhaas EM, Brouwers JR. Intrathecal baclofen overdose: report of 7 events in 5 patients and review of the literature. Int J Clin Pharmacol Ther Toxicol. 1991;29:274–80.PubMedGoogle Scholar
  19. 19.
    Grandas F, Fernandez-Carballal C, Guzman-de-Villoria J, Ampuero I. Treatment of a dystonic storm with pallidal stimulation in a patient with PANK2 mutation. Mov Disord. 2011;26(5):921–2.PubMedCrossRefGoogle Scholar
  20. 20.
    Elkay M, Silver K, Penn RD, Dalvi A. Dystonic storm due to Batten’s disease treated with pallidotomy and deep brain stimulation. Mov Disord. 2009;24:1048–53.PubMedCrossRefGoogle Scholar
  21. 21.
    Apetauerova D, Schirmer CM, Shils JL, Zani J, Arle JE. Successful bilateral deep brain stimulation of the globus pallidus internus for persistent status dystonicus and generalized chorea. J Neurosurg. 2010;113:634–8.PubMedCrossRefGoogle Scholar
  22. 22.
    Paliwal VK, Gupta PK, Pradhan S. Gabapentin as a rescue drug in D-penicillamine-induced status dystonicus in patients with Wilson disease. Neurol India. 2010;58:761–3.PubMedCrossRefGoogle Scholar
  23. 23.
    Mishra D, Singhal S, Juneja M. Status dystonicus a rare complication of dystonia. Indian Pediatr. 2010;47:883–5.PubMedCrossRefGoogle Scholar
  24. 24.
    Ford B, Greene P, Louis ED, et al. Use of intrathecal baclofen in the treatment of patients with dystonia. Arch Neurol. 1996;53:1241–6.PubMedCrossRefGoogle Scholar
  25. 25.
    Muirhead W, Jalloh I, Vloeberghs M. Status dystonicus resembling the intrathecal baclofen withdrawal syndrome: a case report and review of the literature. J Med Case Reports. 2010;4:294.CrossRefGoogle Scholar
  26. 26.
    Teddy P, Jamous A, Gardner B, Wang D, Silver J. Complications of intrathecal baclofen delivery. Br J Neurosurg. 1992;6:115–8.PubMedCrossRefGoogle Scholar
  27. 27.
    Fahn S. High dosage anticholinergic therapy in dystonia. Neurology. 1983;33:1255–61.PubMedCrossRefGoogle Scholar
  28. 28.
    Penn RD. Intrathecal baclofen for spasticity of spinal origin: seven years of experience. J Neurosurg. 1992;77:236–40.PubMedCrossRefGoogle Scholar
  29. 29.
    Kravitz HM, Corcos DM, Hansen G, Penn RD, Cartwright RD, Gianino J. Intrathecal baclofen: effects on nocturnal leg muscle spasticity. Am J Phys Med Rehabil. 1992;71:48–52.PubMedCrossRefGoogle Scholar
  30. 30.
    Ford B, Greene PE, Louis ED, et al. Intrathecal baclofen in the treatment of dystonia. Adv Neurol. 1998;78:199–210.PubMedGoogle Scholar
  31. 31.
    Hou JG, Ondo W, Jankovic J. Intrathecal baclofen for dystonia. Mov Disord. 2001;16:1201–2.PubMedCrossRefGoogle Scholar
  32. 32.
    Albright AL, Barry MJ, Shafton DH, Ferson SS. Intrathecal baclofen for generalized dystonia. Dev Med Child Neurol. 2001;43:652–7.PubMedCrossRefGoogle Scholar
  33. 33.
    Walker RH, Danisi FO, Swope DM, Goodman RR, Germano IM, Brin MF. Intrathecal baclofen for dystonia: benefits and complications during six years of experience. Mov Disord. 2000;15:1242–7.PubMedCrossRefGoogle Scholar
  34. 34.
    Silbert PL, Stewart-Wynne EG. Increased dystonia after intrathecal baclofen. Neurology. 1992;42:1639–40.PubMedCrossRefGoogle Scholar
  35. 35.
    Kyriagis M, Grattan-Smith P, Scheinberg A, Teo C, Nakaji N, Waugh M. Status dystonicus and Hallervorden-Spatz disease: treatment with intrathecal baclofen and pallidotomy. J Paediatr Child Health. 2004;40:322–5.PubMedCrossRefGoogle Scholar
  36. 36.
    Jaffe MS, Nienstedt LJ. Intrathecal baclofen for generalized dystonia: a case report. Arch Phys Med Rehabil. 2001;82:853–5.PubMedCrossRefGoogle Scholar
  37. 37.
    Penn RD, Gianino JM, York MM. Intrathecal baclofen for motor disorders. Mov Disord. 1995;10:675–7.PubMedCrossRefGoogle Scholar
  38. 38.
    Siegfried RN, Jacobson L, Chabal C. Development of an acute withdrawal syndrome following the cessation of intrathecal baclofen in a patient with spasticity. Anesthesiology. 1992;77:1048–50.PubMedCrossRefGoogle Scholar
  39. 39.
    Kupsch A, Kuehn A, Klaffke S, et al. Deep brain stimulation in dystonia. J Neurol. 2003;250 Suppl 1:I47–52.PubMedCrossRefGoogle Scholar
  40. 40.
    Yianni J, Bain PG, Gregory RP, et al. Post-operative progress of dystonia patients following globus pallidus internus deep brain stimulation. Eur J Neurol. 2003;10:239–47.PubMedCrossRefGoogle Scholar
  41. 41.
    Krauss JK, Loher TJ, Weigel R, Capelle HH, Weber S, Burgunder JM. Chronic stimulation of the globus pallidus internus for treatment of non-DYT1 generalized dystonia and choreoathetosis: 2-year follow up. J Neurosurg. 2003;98:785–92.PubMedCrossRefGoogle Scholar
  42. 42.
    Yianni J, Bain P, Giladi N, et al. Globus pallidus internus deep brain stimulation for dystonic conditions: a prospective audit. Mov Disord. 2003;18:436–42.PubMedCrossRefGoogle Scholar
  43. 43.
    Krauss JK. Deep brain stimulation for dystonia in adults: overview and developments. Stereotact Funct Neurosurg. 2002;78:168–82.PubMedCrossRefGoogle Scholar
  44. 44.
    Vercueil L, Pollak P, Fraix V, et al. Deep brain stimulation in the treatment of severe dystonia. J Neurol. 2001;248:695–700.PubMedCrossRefGoogle Scholar
  45. 45.
    Krack P, Vercueil L. Review of the functional surgical treatment of dystonia. Eur J Neurol. 2001;8:389–99.PubMedCrossRefGoogle Scholar
  46. 46.
    Ondo WG, Desaloms JM, Jankovic J, Grossman RG. Pallidotomy for generalized dystonia. Mov Disord. 1998;13:693–8.PubMedCrossRefGoogle Scholar
  47. 47.
    Balas I, Kovacs N, Hollody K. Staged bilateral stereotactic pallidothalamotomy for life-threatening dystonia in a child with Hallervorden-Spatz disease. Mov Disord. 2006;21:82–5.PubMedCrossRefGoogle Scholar
  48. 48.
    Jech R, Bares M, Urgosik D, et al. Deep brain stimulation in acute management of status dystonicus. Mov Disord. 2009;24:2291–2.PubMedCrossRefGoogle Scholar
  49. 49.
    Zorzi G, Marras C, Nardocci N, et al. Stimulation of the globus pallidus internus for childhood-onset dystonia. Mov Disord. 2005;20:1194–200.PubMedCrossRefGoogle Scholar
  50. 50.
    Beric A, Kelly PJ, Rezai A, et al. Complications of deep brain stimulation surgery. Stereotact Funct Neurosurg. 2001;77:73–8.PubMedCrossRefGoogle Scholar
  51. 51.
    Lozano AM, Kumar R, Gross RE, et al. Globus pallidus internus pallidotomy for generalized dystonia. Mov Disord. 1997;12:865–70.PubMedCrossRefGoogle Scholar
  52. 52.
    Abosch A, Lozano A. Stereotactic neurosurgery for movement disorders. Can J Neurol Sci. 2003;30 Suppl 1:S72–82.PubMedGoogle Scholar
  53. 53.
    Hariz MI, De Salles AA. The side-effects and complications of posteroventral pallidotomy. Acta Neurochir Suppl. 1997;68:42–8.PubMedGoogle Scholar
  54. 54.
    Hariz MI. Complications of deep brain stimulation surgery. Mov Disord. 2002;17 Suppl 3:S162–6.PubMedCrossRefGoogle Scholar
  55. 55.
    Angelini L, Nardocci N, Estienne M, Conti C, Dones I, Broggi G. Life-threatening dystonia-dyskinesias in a child: successful treatment with bilateral pallidal stimulation. Mov Disord. 2000;15:1010–2.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2013

Authors and Affiliations

  1. 1.Division of Movement DisordersNew York University School of MedicineNew YorkUSA
  2. 2.Department of Neurology, Neurological InstituteColumbia University Medical Center/New York Presbyterian HospitalNew YorkUSA

Personalised recommendations